Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human IRS1 ELISA Kit (AC2502)
Cat.#: ASET-1091
Specifications
Description Human IRS1 ELISA Kit allows for the in vitro quantitative determination of human IRS1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2121 Human CaSR ELISA Kit (AC3532) Quantitative inquiry ASET-1510 Rat Semaphorin 7a ELISA Kit (AC2921) Quantitative inquiry ASET-1636 Mouse Insulin Receptor beta ELISA Kit (AC3047) Quantitative inquiry ASET-1517 Mouse PSD95 ELISA Kit (AC2928) Quantitative inquiry ASET-1503 Mouse NMDAR2A ELISA Kit (AC2914) Quantitative inquiry ASET-1138 Human LUZP1 ELISA Kit (AC2549) Quantitative inquiry ASET-1208 Mouse Adiponectin ELISA Kit (AC2619) Quantitative inquiry ASET-1336 Human SOX6 ELISA Kit (AC2747) Quantitative inquiry ASET-2202 Human Estrogen Receptor beta ELISA Kit (AC3613) Quantitative inquiry ASET-2399 Human PITPNC1 ELISA Kit (AC3810) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket